Eton Pharmaceuticals (ETON) Enterprise Value (2017 - 2025)
Eton Pharmaceuticals (ETON) reported Enterprise Value of -$25.9 million for Q4 2025, down 73.69% on a YoY basis from -$98.6 million in Q4 2024, and up 30.12% sequentially from -$37.1 million in Q3 2025.
Eton Pharmaceuticals (ETON) Enterprise Value (2017 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 9 years of Enterprise Value data on file, last reported at -$25.9 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 73.69% year-over-year to -$25.9 million; the trailing twelve-month figure through Dec 2025 stood at -$25.9 million (down 73.69% YoY), and the FY2025 full-year result was -$25.9 million, down 73.69% from the prior year.
- Enterprise Value advanced to -$25.9 million in Q4 2025, from -$37.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$13.4 million in Q3 2022 to a low of -$37.1 million in Q3 2025.
- A 5-year average of -$20.3 million and a median of -$19.0 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value plunged 209.72% in 2021 and surged 41.09% in 2022, its largest moves.
- Tracing ETON's Enterprise Value over 5 years: stood at -$14.4 million in 2021, then fell by 13.18% to -$16.3 million in 2022, then sank by 31.17% to -$21.4 million in 2023, then soared by 30.17% to -$14.9 million in 2024, then slumped by 73.69% to -$25.9 million in 2025.
- Business Quant data shows ETON's Enterprise Value at -$25.9 million in Q4 2025, -$37.1 million in Q3 2025, and -$25.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | -25.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25.94 Mn |
| Sep 30, 2025 | -37.12 Mn |
| Jun 30, 2025 | -25.38 Mn |
| Mar 31, 2025 | -17.42 Mn |
| Dec 31, 2024 | -14.94 Mn |
| Sep 30, 2024 | -20.26 Mn |
| Jun 30, 2024 | -17.69 Mn |
| Mar 31, 2024 | -16.66 Mn |
| Dec 31, 2023 | -21.39 Mn |
| Sep 30, 2023 | -22.07 Mn |
| Jun 30, 2023 | -21.57 Mn |
| Mar 31, 2023 | -14.71 Mn |
| Dec 31, 2022 | -16.31 Mn |
| Sep 30, 2022 | -13.38 Mn |
| Jun 30, 2022 | -17.05 Mn |
| Mar 31, 2022 | -15.23 Mn |
| Dec 31, 2021 | -14.41 Mn |
| Sep 30, 2021 | -22.71 Mn |
| Jun 30, 2021 | -25.80 Mn |
| Mar 31, 2021 | -25.11 Mn |